PM Modi visits Bharat Biotech's vaccine manufacturing facility in Hyderabad

Covaxin, being developed by Bharat Biotech in collaboration with the
Indian Council of Medical Research and National Institute of Virology,
is now undergoing phase-3 trials. The Phase-3 trials involve 26,000
volunteers across India, conducted in partnership with ICMR.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pm-modi-visits-bharat-biotechs-vaccine-manufacturing-facility-in-hyderabad/articleshow/79462953.cms

Comments

Popular posts from this blog

Lupin, Aurobindo units recall products in US market

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

Data Analyst Jobs – Life Sciences Apply at Cognizant